Recent developments and future prospects in the treatment of visceral leishmaniasis
Therapeutic Advances in Infectious Disease, 2016 S. Sundar, Anup Singh
semanticscholar +1 more source
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case [PDF]
, 2018 Maria Antonia Ferreira Gomes +7 more
openalex +1 more source
Design of a novel multi epitope antigen for diagnosis of visceral leishmaniasis using an immunoinformatics approach. [PDF]
Sci RepBaneshi M +7 more
europepmc +1 more source
A Century of Epidemiological Advances in Cutaneous and Visceral Leishmaniasis in Algeria. [PDF]
J Parasitol ResEddaikra N, Benikhlef R, Sereno D.
europepmc +1 more source
Visceral Leishmaniasis Masquerading as Drug-Induced Pancytopenia in Lung Cancer Patients [PDF]
Sophie Laroumagne +3 more
openalex +1 more source
Visceral Leishmaniasis in London
International Journal of Clinical Practice, 1972 openaire +2 more sources
Visceral leishmaniasis outbreak investigation and risk factors among communities in South Omo Zone, Southern Ethiopia, 2022-2023. [PDF]
Parasite Epidemiol ControlAngo TS, Dana DD, Getachew S, Deressa W.
europepmc +1 more source
Additional file 3: of Revisiting area risk classification of visceral leishmaniasis in Brazil
, 2019 Gustavo Machado +7 more
openalex +1 more source
The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities. [PDF]
Parasit VectorsSingh-Phulgenda S +14 more
europepmc +1 more source